Diagnostic approach in adult-onset neurometabolic diseases

Gorka Fernández-Eulate1,2, Christophe Carreau3, Jean-François Benoist4

  • 1Neuro-Metabolism Unit, Reference Center for Lysosomal Diseases, Neurology Department, Pitié-Salpêtrière University Hospital, APHP, Paris, France.

Insights

Neurometabolic diseases, though rare, are treatable genetic disorders often missed in adults. Early diagnosis is crucial for effective management and improved patient outcomes.

Area of Science:

  • Neurology
  • Genetics
  • Biochemistry

Background:

  • Neurometabolic diseases are numerous, heterogeneous genetic disorders.
  • Adult-onset forms present unique challenges, mimicking common neurological conditions.
  • Many neurometabolic diseases are treatable, yet face diagnostic delays due to complexity.

Purpose of the Study:

  • To review treatable neurometabolic diseases with adult neurological onset.
  • To classify these diseases by clinical manifestations.
  • To propose a simplified diagnostic approach for neurologists.

Main Methods:

  • Systematic review of case reports and series of patients with neurological onset after age 10.
  • Focus on 36 treatable neurometabolic diseases.
  • Classification based on clinical manifestations and discussion of diagnostic biochemical tests and therapeutics.

Main Results:

  • Identified and classified treatable neurometabolic diseases presenting in adults.
  • Highlighted the diagnostic delay and underdiagnosis issues.
  • Emphasized the impact of timely diagnosis on patient stabilization and familial screening.

Conclusions:

  • A simplified diagnostic approach can aid neurologists in suspecting and managing neurometabolic diseases.
  • Next-generation sequencing, coupled with deep phenotyping, is vital for improving diagnostic yield.
  • Early and accurate diagnosis of treatable neurometabolic disorders significantly benefits patients.